CD8A and cancer: Consistent with a cross-priming function of VentX-TAMs, we found that phagocytosis of cancer cells but not normal epithelial cells by VentX-TAMs led to about 4-fold enhancement of CD8 T cell proliferation and activation (Figures 5B–5D).